Groundbreaking for first R&D vaccine center in the Middle East takes place at KAUST
KAUST · · Significant research
Summary
The Saudi Vaccine and Biomanufacturing Center (SVBC), the first of its kind in the Middle East, broke ground at KAUST on December 15. The center will develop vaccines and biopharmaceutical products under good manufacturing practice (GMP) standards. It is a joint project championed by the Ministry of Energy, Industry and Mineral Resources through the Industrial Clusters Program and supported by KACST. Why it matters: The center will serve as a national platform for pharmaceutical innovation and address epidemic risks in the Kingdom, such as MERS-CoV.
Keywords
KAUST · Vaccine · Biomanufacturing · KACST · SaudiVax
Get the weekly digest
Top AI stories from the GCC region, every week.